Article metrics

Original article
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

 

Online download statistics by month:

Online download statistics by month: November 2014 to August 2021

AbstractFullPdf
Nov 20142835767
Dec 201431612887
Jan 20159710886
Feb 2015908756
Mar 201518610889
Apr 2015805850
May 2015566451
Jun 2015666135
Jul 2015655947
Aug 2015697457
Sep 2015395967
Oct 2015325433
Nov 201587970101
Dec 20155667947
Jan 20162634752
Feb 20161665242
Mar 20161272429
Apr 20161345047
May 2016944824
Jun 2016733335
Jul 2016716151
Aug 2016865135
Sep 2016733228
Oct 2016533526
Nov 2016695083
Dec 2016633222
Jan 2017633820
Feb 201752718
Mar 201732714
Apr 201725233
May 201735020
Jun 2017144113
Jul 2017444118
Aug 201749367
Sep 2017654515
Oct 2017705619
Nov 2017735842
Dec 2017524624
Jan 2018988818
Feb 2018786827
Mar 2018686432
Apr 2018504619
May 20181008421
Jun 2018867422
Jul 2018114924
Aug 2018795414
Sep 2018694322
Oct 2018524522
Nov 2018756124
Dec 2018746827
Jan 2019878143
Feb 2019976836
Mar 2019936925
Apr 2019986236
May 2019413521
Jun 2019958220
Jul 2019746222
Aug 2019736552
Sep 2019644832
Oct 2019564828
Nov 20191115722
Dec 20192285511
Jan 2020726523
Feb 2020453720
Mar 2020968730
Apr 2020716517
May 2020655416
Jun 2020545111
Jul 2020524622
Aug 2020585010
Sep 2020655319
Oct 2020714420
Nov 2020584812
Dec 2020705729
Jan 2021756613
Feb 2021282113
Mar 2021674826
Apr 2021948818
May 2021706516
Jun 2021555516
Jul 2021292917
Aug 2021323219
Total782646782557